Abstract
Understanding of how to analyse and interpret quality of life (QoL) data from clinical trials in patients with advanced cancer is limited. In order to increase the knowledge about the possibilities of drawing conclusions from QoL data of these patients, data from 2 trials were reanalysed. A total of 113 patients with pancreatic, biliary or gastric cancer were included in 2 randomised trials comparing chemotherapy and best supportive care (BSC) with BSC alone. Patient benefit was evaluated by the treating physician (subjective response) and by using selected scales and different summary measures of the EORTC QLQ-C30 questionnaire. An increasing number of drop-outs (mainly due to death) with time did not occur in a random fashion. Therefore, the mean scores in the different subscales of the QLQ-C30 obtained during the follow-up of interviewed patients did not reflect the outcome of the randomised population. The scores of the patient-provided summary measure, ‘Global health status/QoL', were stable in a rather high proportion of the patients and could not discriminate between the 2 groups. 3 other summary measures revealed greater variability, and they all discriminated between the 2 groups. A high agreement was also seen between the changes in the summary measures and the subjective response. A categorisation of whether an individual patient had benefited or not from the intervention could overcome the problem with the selective attrition. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB and Haes JCd (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in clinical trials in oncology. J Natl Cancer Inst 85: 365–376
Andrykowski M, Brady M and Hung J (1993) Positive psychological adjustment in potential bone marrow transplant recipients: Cancer as a psychosocial transition. Psycho-Oncol 2: 261–276
Bergman B, Sullivan M and Sörenson S (1991) Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures. Acta Oncol 30: 947–957
Bernhard J, Cella D, Coates A, Fallowfield L, Ganz P, Moinpour C, Mosconi P, Osboa D, Simes J and Hürny C (1998) Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 17: 517–532
Bernhard J, Hurny C, Maibach R, Herrmann R and Laffer U (1999) Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol 10: 775–782
Bjordal K and Kaasa S (1992) Psychometric validation of the EORTC core quality of life questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 31: 311–321
Breetvelt I and Van Dam F (1991) Underreporting by cancer patients: The case of response shift. Social Science & Medicine 32: 981–987
Campell S and Whyte F (1999) Quality of life in cancer patients participating in phase I clinical trials using SEIQoL-DW. Methodological issues. Nursing Research 30: 335–343
Cassileth B, Lusk E and Tenaglia A (1984) A psychological comparison of patients with melanoma and other dermatological disordes. Am Academy Dermatol 7: 742–746
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P, Kaplan E, IV ST, CR Thomas J and Harris J (1993) The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11: 570–579
Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ and Jones DR (1992) Quality-of-life assessment: Can we keep it simple?. J R Statist Soc 155: 353–393
Curran D, Fossa S, Aaronson N, Kiebert G, Keuppens E and Hall R (1997) Baseline quality of life of patients with advanced prostate cancer. Eur J Cancer 33: 1809–1814
de Haes JC, van Knippenberg FC and Neijt J (1990) Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62: 1034–1038
Detmar SB, Aaronson NK, Wever LD, Muller M and Schornagel JH (2000) How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. J Clin Oncol 18: 3295–3301
Diggle P and Kenward MG (1994) Informative drop-out in longitudinal data analysis. Appl Statist 43: 49–93
Fayers P, Aaronson N, Bjordal K and M Sullivan (1995) EORTC QLQ-C30 Scoring Manual. EORTC Quality of Life Study Group: 1–25
Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D and Stephens R (1997) On behalf of the MRC Cancer Trials Office. Quality of life assessment in clinical trials–Guidelines and a checklist for protocol writers: the U.K. Medical Research Council Experience. Eur J Cancer 33: 20–28
Glimelius B, Hoffman K, Olafsdottir M, Påhlman L, Sjödén P and Wennberg A (1989) Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma. A randomized comparison of two regimens. Eur J Cancer Clin Oncol 25: 829–835
Glimelius B, Graf W, Hoffman K, Påhlman L, Sjödén PO and Wennberg A (1992) General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy: A longitudinal study. Acta Oncol 31: 645–651
Glimelius B, Hoffman K, Graf W, Påhlman L, Sjödén P-O and Wennberg A (1994) Quality of life during chemotherapy in symptomatic patients with advanced colorectal cancer. Cancer 73: 556–562
Glimelius B, Hoffman K, Sjödén P-O, Jacobsson G, Sellström H, Enander L-K, Linné T and Svensson C (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7: 593–600
Glimelius B, Ekström K, Hoffman K, Graf W, Sjödén P-O, Haglund U, Svensson C, Enander L-K, Linné T, Sellström H and Heuman R (1997) Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8: 163–168
Guyatt GH, Veldhuyzen Van Zanten SJ, Feeny DH and Patrick DL (1989) Measuring quality of life in clinical trials: a taxonomy and review. CMAJ 140: 1441–1448
Gunnars B, Nygren P and Glimelius B (2001) Assessment of quality of life during chemotherapy. Acta Oncol 40: 175–184
Hopwood P, Stephens RJ and Machin D (1994) Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 3: 339–352
Juniper EF, Guyatt GH, Willan A and Griffith LE (1994) Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 47: 81–87
Kaasa S, Mastekaasa A, Stokke I and Naess S (1988) Validation of a quality of life questionnaire for use in clinical trials for treatment of patients with inoperable lung cancer. Eur J Clin Oncol 24: 691–701
Labianca R, Pancera G and Luporini G (1996) Factors influencing response rates for advanced gastrointestinal cancer chemotherapy. Ann Oncol 7: 901–906
Lydick E and Epstein RS (1993) Interpretation of quality of life changes. Qual Life Res 2: 221–226
Matthews JNS (1993) A refinement to the analysis of serial data using summary measures. Stat Med 12: 27–37
Moinpour CM, Sawyers Triplett J, McKnight B, Lovato LC, Upchurch C, Leichman CG, Muggia FM, Tanaka L, James WA, Lennard M and Meyskens, Jr. FL (2000) Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psychooncology 9: 340–354
Molenberghs G, Kenward MG and Lesaffre E (1997) The analysis of longitudinal ordinal data with nonrandom drop-out. Biometrika 84: 33–44
Morris J, Perez D and McNoe B (1998) The use of quality of life data in clinical practice. Qual Life Res 7: 85–91
Nordic Gastrointestinal Tumor Adjuvant Therapy Group (1993) Biochemical modulation of 5-fluorouracil: A randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. Ann Oncol 4: 235–241
O'Boyle CA, McGee H, Hickey A, O'Malley K and Joyce CR (1992) Individual quality of life in patients undergoing hip replacement. Lancet 339: 1088–1091
Osboa D, Rodrigues G, Myles J, Zee B and Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16: 139–144
Ross PJ, Webb A, Cunningham D, Prediville J, Norman AR and Oates J (1997) Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience. Ann Oncol 8: 111–115
Rothenberg aL, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM and Hoff DDV (1996) A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 7: 347–353
Sanders C, Egger M, Donovan J, Tallon D and Frankel S (1998) Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 317: 1191–1194
Schag CAC, Ganz PA and Heinrich RL (1991) Cancer Rehabilitation Evaluation System-Short Form (CARES-SF): A cancer specific rehabilitation and quality of life instrument. Cancer 68: 1406–1413
Schipper H (1990) Quality of Life: Principles of the clinical paradigm. J Psychosocial Oncol 8: 171–185
Sigurdadóttir V, Bolund C and Sullivan M (1996) Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy. Acta Oncol 35: 149–159
Sprangers MA and Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48: 1507–1515
Sprangers M, te Velde A and Aaronson N (1999a) The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). Eur J Cancer 35: 238–247
Sprangers M, Van Dam F, Broersn J, Lodder L, Wever L, Visser M, Oosterveld P and Smets E (1999b) Revealing response shift in longitudinal research on fatigue-the use of the thentest approach. Acta oncol 38: 709–718
Troxel A, Fairclough D, Curran D and Hahn E (1998) Statistical analysis of quality of life with missing data in cancer clinical trials. Stat Med 17: 653–666
Wilke H, Preusser P, Stahl M, Harstrick A, Meyer HJ, Achterrath W, Schmoll HJ and Seeber S (1991) Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer. Cancer Chemother Pharmacol 29: 83–84
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Nordin, K., Steel, J., Hoffman, K. et al. Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients. Br J Cancer 85, 1265–1272 (2001). https://doi.org/10.1054/bjoc.2001.2046
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.2046
Keywords
This article is cited by
-
A comprehensive analysis of the association between anemia and systemic inflammation in older patients with cancer
Supportive Care in Cancer (2024)
-
Changes in patients’ quality of life during radiotherapy and 1 month after treatment
memo - Magazine of European Medical Oncology (2019)
-
Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis
Bone Marrow Transplantation (2018)
-
Health-related quality of life among cancer patients in their last year of life: results from the PROFILES registry
Supportive Care in Cancer (2018)
-
A Prospective Study of Patient Reported Outcomes in Pancreatic and Peri‐ampullary Malignancy
World Journal of Surgery (2013)
